about
Characterization of damaged skin by impedance spectroscopy: mechanical damageCharacterization of damaged skin by impedance spectroscopy: chemical damage by dimethyl sulfoxideA critical analysis of single-frequency LCR databridge impedance measurements of human skinAnalysis of finite dose dermal absorption data: implications for dermal exposure assessmentThe transient dermal exposure II: post-exposure absorption and evaporation of volatile compoundsDermally adhered soil: 2. Reconstruction of dry-sieve particle-size distributions from wet-sieve data.Characterization of Water and a Model Lipophilic Compound in Human Stratum Corneum by NMR Spectroscopy and Equilibrium Sorption.Pharmacokinetic models of dermal absorption.A new method for estimating dermal absorption from chemical exposure. 3. Compared with steady-state methods for prediction and data analysis.Dermal absorption of environmental contaminants from soil and sediment: a critical review.A Coarse-Grained Model of Stratum Corneum Lipids: Free Fatty Acids and Ceramide NS.Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.Oral Bioavailability, Bioaccessibility, and Dermal Absorption of PAHs from Soil-State of the Science.Dermal absorption of benzo[a]pyrene into human skin from soil: Effect of artificial weathering, concentration, and exposure duration.A new method for estimating dermal absorption from chemical exposure: 2. Effect of molecular weight and octanol-water partitioning.Measuring the saturation limit of low-volatility organic compounds in soils: implications for estimates of dermal absorption.Assessment of dermal exposure to pesticide residues during re-entry.Uncertainty in measurements of dermal absorption of pesticides.Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials.Percutaneous absorption of 4-cyanophenol from freshly contaminated soil in vitro: effects of soil loading and contamination concentration.Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.Dermally adhered soil: 1. Amount and particle-size distribution.Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model.Molecular dynamics simulations of stratum corneum lipid mixtures: A multiscale perspective.Optimizing metrics for the assessment of bioequivalence between topical drug products.Topical bioavailability of diclofenac from locally-acting, dermatological formulations.The determination of a diffusional pathlength through the stratum corneum.Permeation of 4-cyanophenol and methyl paraben from powder and saturated aqueous solution through silicone rubber membranes and human skin.Nanoparticles do not penetrate human skin--a theoretical perspective.Determining bioequivalence of topical dermatological drug products by tape-stripping.Does epidermal turnover reduce percutaneous penetration?Physiologically relevant two-compartment pharmacokinetic models for skin.Release rates from topical formulations containing drugs in suspension.Physiologically relevant one-compartment pharmacokinetic models for skin. 2. Comparison of models when combined with a systemic pharmacokinetic model.Percutaneous absorption of benzoic acid across human skin. II. Prediction of an in vivo, skin-flap system using in vitro parameters.Comments on Pettyet al.(2011), “A quantitative method for estimating dermal benzene absorption from benzene-containing hydrocarbon liquids,” IJOEH, 17:287–300Dermal exposure and absorption of chemicalsChemical release from topical formulations across synthetic membranes: infinite dosePhysiologically relevant one-compartment pharmacokinetic models for skin. 1. Development of modelsComment on Sartorelli et Al. (1998): invalid calculation of permeability coefficients
P50
Q23912602-49BCDC83-2B3B-4FF0-8226-33DA93F2A05AQ23912603-45E60A5D-9DE4-466E-A184-0864791A6099Q23912604-80872E09-9216-4572-897B-9643AF873E3EQ23913352-812B9FAF-47EF-4B8A-A1B5-2DCE9A5AE333Q24169624-B638666F-D157-4D2B-B5FB-06A888C2BF71Q31070752-0C020262-C6A9-4236-835E-74F55EE340D4Q31133263-044070CD-CBBE-433D-B151-0A3DFC3D6782Q34105294-9EDC42F7-2265-481B-9DDA-25C66E4EA070Q36671996-2BF0C696-BC72-4793-A619-2512B391D9B9Q37284665-FB4859C1-C20C-46D1-B1C5-C0826B6B5613Q37619317-A3821023-730E-4C2C-8140-D57611FEC1C5Q37680039-C574A135-B092-4AB4-9DF7-CA8945385BC5Q38715726-EC0D682E-EB1B-489B-907E-B43093C4180CQ40496673-C0082524-6112-450F-BFE4-F10E783FBCDCQ42278750-3C914EA4-518B-48D6-A100-DF1E2BCF66A0Q42863830-9A912CBE-3115-4F87-A1D2-38FE7236033FQ43918558-9D04D843-49EA-4BB2-8BCE-E4F9D21E62AFQ44280173-C476396B-FC4C-4BB6-A443-6A1E31B63C11Q45235376-159ACF91-3FE5-4BE2-8152-8C63BEEE1899Q46162819-D39AC17C-896A-4BF0-B845-E85CF638C705Q46304674-CFCCB2C0-ECA1-4BAD-BBDF-C06A27B9DABBQ47315788-A8391C1A-4263-4B10-90FB-6A61077AAFB4Q47357924-39FD6C05-4AD4-4644-A6AB-EA2F94FC35D7Q47674473-CEC48CD6-9D96-4D17-A00E-3F02E7AB7A5DQ47736832-37EF06DD-3E0C-4F79-8F53-ACB720C906DFQ47998142-E8BD62E2-1117-43F5-A55F-521A4A9E7359Q50142477-143F79F2-1587-4868-8E83-6B2AC186D31DQ51139927-23DE0E61-3EFC-468D-94B8-C2A4238C7F0BQ51210526-95C7CC57-8EFA-4849-A908-CB678D67C06FQ51886819-8998DD0A-1C67-4834-8917-C14D19FD720DQ52067848-486A710C-FC90-4976-BB43-6FCF5799BF16Q52075242-73971995-DFA4-4295-8ABC-40820B152A3BQ52238850-DA690A9B-D7D1-49C3-AE8F-6D7D395BEA68Q52245247-6FC7118C-8997-4BC6-9E5F-C85513328990Q52487986-74813A40-43E3-45AE-AA65-27B5F01E67D0Q60430570-7D5D3B04-780A-4FD1-B447-170AD32DCBB6Q66630564-99DDC5EB-126B-458D-A1BD-19885795B7E9Q73088445-7A1FCF26-4940-4996-B301-4C73C39B9163Q74457414-D279B668-E8AE-40F7-AC81-47973654CFDFQ78969252-3057BE26-9850-47F2-9691-51356CDBC5EA
P50
description
researcher ORCID ID = 0000-0002-0287-3724
@en
name
Annette L Bunge
@ast
Annette L Bunge
@en
Annette L Bunge
@nl
type
label
Annette L Bunge
@ast
Annette L Bunge
@en
Annette L Bunge
@nl
prefLabel
Annette L Bunge
@ast
Annette L Bunge
@en
Annette L Bunge
@nl
P31
P496
0000-0002-0287-3724